Changes the following terms for purposes of the community mental health services act: (1) From "opiate substitution treatment programs" to "opioid treatment programs"; and

(2) From "addicted baby" to "substance-exposed baby."

Requires the following to adopt rules establishing requirements for prescribing opioid drugs: (1) The podiatric medical board;

(2) The dental quality assurance commission;

(3) The board of osteopathic medicine and surgery;

(4) The medical quality assurance commission; and

(5) The nursing care quality assurance commission.

Recognizes as evidence-based for the management of opioid use disorder, the medications approved by the federal food and drug administration for the treatment of opioid use disorder.

Declares that a person lawfully possessing or using lawfully prescribed medication for the treatment of opioid use disorder must be treated the same in judicial and administrative proceedings as a person lawfully possessing or using other lawfully prescribed medications.

Defines "opioid treatment program" as a program dispensing: (1) A medication approved by the federal drug administration for the treatment of opioid use disorder; and

(2) A medication for the reversal of opioid overdose.

Authorizes a county to impose a maximum capacity for the program of not less than three hundred fifty participants if necessary to address specific local conditions cited by the county.

Subjects opioid treatment programs to the oversight required for other substance use disorder treatment programs, as described in the community mental health services act.